Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice
Gavilá, Joaquín, Guerrero, Ángel, Climent, Miguel Ángel, Fernández, Aranzazu, Gozalbo, Francisco, Carrascosa, María, Camps, Josefina, Guillem, Vicente, Ruiz, AmparoVolume:
20
Language:
english
Journal:
International Journal of Clinical Oncology
DOI:
10.1007/s10147-014-0727-x
Date:
June, 2015
File:
PDF, 264 KB
english, 2015